Read + Share
Amedeo Smart
Independent Medical Education
Oki E, Emi Y, Yamanaka T, Uetake H, et al. Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial). Br J Cancer 2019;121:222-229.PMID: 31285591
Email
LinkedIn
Facebook
Twitter
Privacy Policy